Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.49 USD | -10.49% | -19.74% | -36.65% |
05-07 | Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading | MT |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
Sales 2024 * | 206M 282M | Sales 2025 * | 183M 251M | Capitalization | 220M 301M |
---|---|---|---|---|---|
Net income 2024 * | -175M -239M | Net income 2025 * | -223M -305M | EV / Sales 2024 * | 1.07 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.2 x |
P/E ratio 2024 * |
-1.18
x | P/E ratio 2025 * |
-1.21
x | Employees | 389 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.79% |
Latest transcript on Agenus Inc.
1 day | -10.49% | ||
1 week | -19.74% | ||
Current month | -13.45% | ||
1 month | +17.57% | ||
3 months | -29.89% | ||
6 months | -19.32% | ||
Current year | -36.65% |
Managers | Title | Age | Since |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 94-03-30 |
Director of Finance/CFO | 58 | 95-12-31 | |
Craig Winter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 71 | 94-03-30 |
Director/Board Member | 66 | 16-05-16 | |
Susan Hirsch
BRD | Director/Board Member | 71 | 20-10-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 0 M€ | -2.98% | - | |
0.01% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 10.49 | -10.49% | 831,166 |
24-05-09 | 11.72 | +2.18% | 561,109 |
24-05-08 | 11.47 | -4.50% | 717,486 |
24-05-07 | 12.01 | -7.26% | 1,268,606 |
24-05-06 | 12.95 | -0.92% | 417,963 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.65% | 220M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- AGEN Stock